Mela Sciences (MELA -10.6%) takes a hit today after its Q1 revenue misses by a huge margin despite a nearly 12-fold increase over year-ago levels. Revenue for the three months ended March 31 totaled $144,100, up from $11,250 during the same quarter last year but still lagging the analyst consensus by more than 76%, as a sizeable chunk of the quarters revenue from Melafind sales were deferred.
Mela Sciences (MELA -10.6%) takes a hit today after its Q1 revenue misses by a huge margin...
Recommended For You
About SSKN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SSKN | - | - |
STRATA Skin Sciences, Inc. |